US equities |
MU $905.34 ▼-0.96% NVDA $216.79 ▼-2.04% SNDK $1,347.24 ▼-4.00% SPCX $146.76 ▼-3.55% AMD $546.89 ▼-4.19% INTC $93.27 ▼-4.94% TSM $416.90 ▼-3.05% AAPL $344.61 ▲+0.48%
FinancialContent

Embecta Corp. - Common Stock (NQ:EMBC)

6.500 +0.320 (+5.18%)
Delayed Quote Updated: 10:47 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Embecta Corp. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Embecta (EMBC) Q3 2026 Earnings Call Transcript ↗
Revenue fell 8.1% year-over-year, but margin guidance rose for fiscal 2026. 
Via The Motley Fool
Topics Earnings
News headline image
Embecta Q3 Earnings Call Highlights ↗
Embecta (NASDAQ:EMBC) reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% from the prior-year period on a reported basis and down 8.9% on an adjusted constant-currency... 
Via MarketBeat
Topics Earnings
Embecta (NASDAQ:EMBC) Jumps 9% on Strong Fiscal Q3 Earnings Beat ↗
Via Chartmill
News headline image
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification ↗
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and... 
Via MarketBeat
Embecta Corp. (NASDAQ:EMBC) Plunges Over 25% on Q2 Fiscal 2026 Miss ↗
Via Chartmill
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat ↗
Via Chartmill
News headline image
An Overview of Embecta's Earnings ↗
 
Via Benzinga
News headline image
A Peek at Embecta's Future Earnings ↗
 
Via Benzinga
News headline image
Why Embecta Stock Plummeted Today ↗
Embecta's most recent quarterly report didn't give investors much to be exicited about. 
Via The Motley Fool
News headline image
Embecta (EMBC) Q2 2026 Earnings Transcript ↗
Embecta (EMBC) Q2 2026 Earnings Transcript 
Via The Motley Fool
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Earnings Scheduled For February 6, 2025 ↗
 
Via Benzinga
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
Via Finterra
Topics Artificial Intelligence
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5... 
Via Finterra
Topics Artificial Intelligence Economy Product Recall
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗
Which of the highest-yielding healthcare stocks are value traps or golden opportunities? 
Via The Motley Fool
News headline image
Embecta (EMBC) Q1 2026 Earnings Call Transcript ↗
Embecta (EMBC) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)
Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully... 
Via PredictStreet
Topics Economy Product Recall World Trade
News headline image
Embecta (EMBC) Q4 2025 Earnings Call Transcript ↗
Embecta (EMBC) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Embecta Corp (NASDAQ:EMBC) Reports Q4 Earnings Miss, Provides FY 2026 Outlook ↗
Embecta (EMBC) reported Q4 earnings, missing EPS and revenue estimates. The stock rose as investors focused on the company's positive fiscal 2026 guidance and dividend. 
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading ↗
Embecta Corp (EMBC) beats Q3 2025 earnings estimates with $295.5M revenue and $1.12 EPS, sparking a 10.5% pre-market stock surge. Strong performance may lift full-year forecasts. 
Via Chartmill
News headline image
Earnings Scheduled For August 8, 2025 ↗
 
Via Benzinga
News headline image
Why Is Embecta Stock Falling On Friday? ↗
Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds. 
Via Benzinga
Topics World Trade
News headline image
Earnings Scheduled For May 9, 2025 ↗
 
Via Benzinga
News headline image
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business ↗
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance. 
Via Benzinga
News headline image
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit ↗
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to... 
Via Benzinga
News headline image
Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
Topics Government
News headline image
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
< Previous 1 2 3 4 Next >